Susan Soares has served as a longtime local advocate within the cannabis community. She was asked a question about how to broach the subject of cannabis use to children when interviewed about the industry on The Woody Show. While Soares answered the question sufficiently, she’s since reflected on the discontent she felt with her response. This interview led her to the question of cannabis – and how we can most effectively broach the subject of its legal use with children throughout the United States. The changing regulatory standards surrounding cannabis and its medicinal value have increased the openness of its use for a variety of ailments, both physical and psychological. However, as any educator or parent knows, the way we speak to children has tremendous power in the ways the view the world around us. From that day forward, Soares set out to tackle the difficult subject – what’s the best way to talk about cannabis with our nation’s kids?
Millennials are defined as the generation born between 1981 and 1996 – putting them between the ages of 23 and 39. In the classic debate of cannabis versus alcohol, increasing numbers of millennials are declaring cannabis their favorite vice. Last week, we reviewed a few primary reasons for millennials’ increasing preference for cannabis as compared to alcohol. We’ve uncovered a few more major reasons this generation’s leaning toward pipe shops over pitchers.
The “millennial” demographic includes all individuals reaching young adulthood around the start of the 21st century. This has been narrowed to include those born between the years of 1981 and 1996; between the ages of 23 and 39 today. In the age-old debate of cannabis versus alcohol, millennials in the United States have increasingly declared themselves proud members of Team Cannabis. In fact, studies have shown that millennials are embracing cannabis culture at higher rates than any prior generation. So what factors are making cannabis the frontrunner among young adults today?
Earlier this month, members of United States Congress made history with their vote on cannabis-related legislature. By a majority of twenty-four to ten, the Marijuana Opportunity, Reinvestment, and Expungement Act was approved by the United States House Judiciary Committee. With this vote, members of Congress have moved to federally deschedule marijuana by removing it from the Controlled Substances Act. If the bill can pass the Senate, states will be allowed to make their own rulings regarding cannabis and enforce them at the state level, free of undue complications from overarching federal limits.
Many cannabis lovers advocate the plant for its expansive range of reported health benefits. From psychological afflictions like PTSD, ADHD and depression, to physical symptoms like inflammation and chronic pain, users report improvement in a host of difficult maladies. However, many critics of cannabis bypass the pipe shop visits, citing lacking scientific support of largely anecdotal evidence from Mary Jane’s devoted fan-base. Ironically, laws prohibiting the use of the misunderstood substance were largely based in stigma and underdeveloped research – but these same laws prevented the very research that would help uproot them.
Last Fall, Canada became the second nation in the world (after Uruguay) to federally legalize the possession and recreational use of cannabis amongst its citizens. In its approval of the Cannabis Act, they’ve forged a path that the United States could theoretically follow, should our country reach the threshold for federal legalization. Currently, thirty-three of our fifty states have partially or fully approved the legal use of citizens at a state level. It’s baffling that the use and possession of cannabis, which permitted (to some degree) by laws in two-thirds of our nation’s states, are simultaneously considered felonious at the federal level. This creates a number of difficulties that affect industry workers and imbibers alike.
The American opioid epidemic has damaged and ended countless lives across the nation, disproportionately ravaging communities affected by poverty, economic depression or limited access to social mobility. The lack of sufficient healthcare in many American communities further exacerbates the increasing reliance on prescription painkillers to manage the effects of chronic illnesses – and the inability for users to cease their reliance on addictive painkillers, whether or not the original symptoms remain.
Nationwide advocates of CBD rave about its benefits for a broad range of maladies, physical and psychological. For many afflicted with arthritis, epilepsy, anxiety or countless other ailments, CBD has been life-changing, and the benefits felt by users are heralded without any doubt. The success stories, coupled with a lack of side effects or propensity for addiction, have fueled countless users to adopt CBD in their own treatment regiment – and spread the craze to others still. Better yet, unlike THC-heavy products, pure CBD can be found at vape shops and head shops like 710Pipes. While CBD has been life-changing for many, and countless credible sources have conducted research in support of their claims, federal administrators have been slow to meet the public’s demand for research into cannabidiol’s efficacy. PubMed has published research affirming CBD’s role in alleviating the symptoms of more than fifty ailments. As the opioid epidemic rages across the nation, having a non-addictive, non-intoxicating alternative with a significant capacity for relief has been a godsend to users everywhere.
Cannabis and alcohol both have been used by practically every culture for millennia. Both occur naturally without intervention and have played prominent roles is just about every facet of human society at one time or another: from their appreciable roles in scientific innovations to religious practices across the globe. Both have a strong capacity for altering consciousness, but is one of them quantifiably more dangerous than the other? Let’s take a look and find out.
Legislators have recently started to try and regulate this awesome compound – but what is it exactly? CBD is short for Cannabidiol, one of about 80 naturally occurring molecular compounds exclusive to Hemp and Cannabis plants. It is non-psychotropic, meaning it doesn’t produce any of the intoxicating effects usually associated with Cannabis. It does, however, help treat a tremendous range of medical conditions from inflammation to Multiple Sclerosis, Epilepsy and PTSD. In recent years CBD has become a fascination of medical studies and legislators alike – but individuals struggling with a myriad of health problems are the ones who bear the burden of floundering legal policies. Craziest of all: for the first time, it seems, the government has patented a plant.